Avenue Therapeutics, Inc.

ATXI · NASDAQ
Analyze with AI
$0.6506−$0.1394 (−17.65%)
At close:Dec 16, 2025, 3:36 PM UTC
$0.6506+$0.00 (+0%)
After hours:Dec 16, 2025, 3:36 PM UTC
P/E TTM2.76
P/B TTM0.58
P/S TTM1.48
Dividend Yield0%
EPS$0.77
Beta-0.325
Valuation
PEG Ratio0.03
FCF Yield-84.15%
EV / EBITDA0.40
Quality
ROIC-171.75%
Gross Margin100.00%
Cash Conv. Ratio0.46
Growth
Revenue 3Y CAGR
FCF Growth27.51%
Safety
Net Debt / EBITDA0.90
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00

Avenue Therapeutics, Inc. (ATXI) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Avenue Therapeutics, Inc. (ATXI) stock price today?

As of Dec 16, 2025, 3:36 PM UTC, Avenue Therapeutics, Inc. (ATXI) stock is trading at $0.6506. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date ATXI stock quotes for informed trading decisions.

What is Avenue Therapeutics, Inc.'s market capitalization?

Avenue Therapeutics, Inc. (ATXI) has a market capitalization of approximately $2.1M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Avenue Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the ATXI stock price changes.

What is the 52-week range for Avenue Therapeutics, Inc. stock?

Avenue Therapeutics, Inc. (ATXI) stock has traded in a 52-week range of $0.1653 — $2.23. The 52-week range shows the highest and lowest prices at which ATXI traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Avenue Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Avenue Therapeutics, Inc. stock have?

Avenue Therapeutics, Inc. (ATXI) stock recently traded approximately 15 shares. Trading volume indicates market liquidity and investor interest in ATXI. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Avenue Therapeutics, Inc. stock.

Does Avenue Therapeutics, Inc. pay dividends to shareholders?

Yes, Avenue Therapeutics, Inc. (ATXI) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Avenue Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Avenue Therapeutics, Inc.'s intraday price range?

Today, Avenue Therapeutics, Inc. (ATXI) stock has traded in a range of $0.6506 — $0.6506. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring ATXI's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Avenue Therapeutics, Inc. stock data?

AlphaPilot sources real-time ATXI stock quotes, fundamental financial data, and historical price charts for Avenue Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Avenue Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of ATXI stock performance.